Systematic review on intentional non-medical fentanyl use among people who use drugs
- PMID: 38414500
- PMCID: PMC10896833
- DOI: 10.3389/fpsyt.2024.1347678
Systematic review on intentional non-medical fentanyl use among people who use drugs
Abstract
Objectives: Fentanyl is a highly potent opioid and has, until recently, been considered an unwanted contaminant in the street drug supply among people who use drugs (PWUD). However, it has become a drug of choice for an increasing number of individuals. This systematic review evaluated intentional non-medical fentanyl use among PWUD, specifically by summarizing demographic variance, reasons for use, and resulting patterns of use.
Methods: The search strategy was developed with a combination of free text keywords and MeSH and non-MeSH keywords, and adapted with database-specific filters to Ovid MEDLINE, Embase, Web of Science, and PsychINFO. Studies included were human studies with intentional use of non-medical fentanyl or analogues in individuals older than 13. Only peer-reviewed original articles available in English were included.
Results: The search resulted in 4437 studies after de-duplication, of which 132 were selected for full-text review. Out of 41 papers included, it was found that individuals who use fentanyl intentionally were more likely to be young, male, and White. They were also more likely to have experienced overdoses, and report injection drug use. There is evidence that fentanyl seeking behaviours are motivated by greater potency, delay of withdrawal, lower cost, and greater availability.
Conclusions: Among PWUD, individuals who intentionally use fentanyl have severe substance use patterns, precarious living situations, and extensive overdose history. In response to the increasing number of individuals who use fentanyl, alternative treatment approaches need to be developed for more effective management of withdrawal and opioid use disorder.
Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42021272111.
Keywords: addiction; fentanyl; opioid use disorder; overdose crisis; substance use.
Copyright © 2024 Tsang, Wong, Westenberg, Ramadhan, Fadakar, Nikoo, Li, Mathew, Azar, Jang and Krausz.
Conflict of interest statement
PA is a consultant on Indivior-led buprenorphine extended-release studies, which are unrelated to this systematic review. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.
Figures
Similar articles
-
Correlates of fentanyl preference among people who use drugs in Rhode Island.Harm Reduct J. 2024 Sep 14;21(1):169. doi: 10.1186/s12954-024-01089-5. Harm Reduct J. 2024. PMID: 39272059 Free PMC article.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.Harm Reduct J. 2019 Jun 24;16(1):39. doi: 10.1186/s12954-019-0311-9. Harm Reduct J. 2019. PMID: 31234942 Free PMC article.
-
The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review.Prim Care Companion CNS Disord. 2023 Nov 9;25(6):22nr03433. doi: 10.4088/PCC.22nr03433. Prim Care Companion CNS Disord. 2023. PMID: 37976226 Review.
-
Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.CJEM. 2020 Mar;22(2):178-186. doi: 10.1017/cem.2019.471. CJEM. 2020. PMID: 31955714
Cited by
-
Mini-review: Harm reduction strategies among people who intentionally use fentanyl.Addict Behav Rep. 2025 May 24;21:100615. doi: 10.1016/j.abrep.2025.100615. eCollection 2025 Jun. Addict Behav Rep. 2025. PMID: 40503271 Free PMC article.
-
Self-Reported Illicitly Manufactured Fentanyl Use and Associated Health and Substance Use Risks in the United States, 2022.Subst Use Misuse. 2025;60(1):137-141. doi: 10.1080/10826084.2024.2403119. Epub 2024 Sep 12. Subst Use Misuse. 2025. PMID: 39267262
-
Risk of Relapse Following Discharge from Non-Hospital Residential Opioid Use Disorder Treatment: A Systematic Review of Studies Published from 2018 to 2022.Subst Abuse Rehabil. 2025 Apr 23;16:105-118. doi: 10.2147/SAR.S440214. eCollection 2025. Subst Abuse Rehabil. 2025. PMID: 40297541 Free PMC article. Review.
-
Correlates of fentanyl preference among people who use drugs in Rhode Island.Harm Reduct J. 2024 Sep 14;21(1):169. doi: 10.1186/s12954-024-01089-5. Harm Reduct J. 2024. PMID: 39272059 Free PMC article.
-
Exploring the Psychological Side of Fentanyl: A Scoping Review to Disclose the Psychosocial Dimensions of Illicitly Manufactured Fentanyl Users.Health Psychol Res. 2024 Sep 21;12:120958. doi: 10.52965/001c.120958. eCollection 2024. Health Psychol Res. 2024. PMID: 39624107 Free PMC article.
References
-
- Barrueto F, Howland MA, Hoffman RS, Nelson LS. The fentanyl tea bag. Veterinary Hum toxicology. (2004) 46(1):30–1. Available at: https://pubmed.ncbi.nlm.nih.gov/14748415/ - PubMed
Publication types
LinkOut - more resources
Full Text Sources